High Tide Inc (HITI)vsNovartis AG ADR (NVS)
HITI
High Tide Inc
$2.69
+0.75%
HEALTHCARE · Cap: $236.67M
NVS
Novartis AG ADR
$156.08
+3.22%
HEALTHCARE · Cap: $286.29B
Smart Verdict
WallStSmart Research — data-driven comparison
Novartis AG ADR generates 7769% more annual revenue ($56.69B vs $720.47M). NVS leads profitability with a 22.5% profit margin vs -4.6%. NVS earns a higher WallStSmart Score of 51/100 (C-).
HITI
Hold43
out of 100
Grade: D
NVS
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for HITI.
Margin of Safety
-67.2%
Fair Value
$93.84
Current Price
$156.08
$62.24 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 32.8% year-over-year
Earnings expanding 1532.0% YoY
Mega-cap, among the largest globally
Every $100 of equity generates 31 in profit
Strong operational efficiency at 34.6%
Keeps 23 of every $100 in revenue as profit
Generating 5.6B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
Elevated debt levels
Weak financial health signals
ROE of -52.8% — below average capital efficiency
0.8% revenue growth
Grey zone — moderate risk
Elevated debt levels
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : HITI
The strongest argument for HITI centers on Revenue Growth, EPS Growth. Revenue growth of 32.8% demonstrates continued momentum.
Bull Case : NVS
The strongest argument for NVS centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 22.5% and operating margin at 34.6%.
Bear Case : HITI
The primary concerns for HITI are Market Cap, Debt/Equity, Piotroski F-Score.
Bear Case : NVS
The primary concerns for NVS are Revenue Growth, Altman Z-Score, Debt/Equity.
Key Dynamics to Monitor
HITI profiles as a hypergrowth stock while NVS is a value play — different risk/reward profiles.
HITI carries more volatility with a beta of 0.95 — expect wider price swings.
HITI is growing revenue faster at 32.8% — sustainability is the question.
NVS generates stronger free cash flow (5.6B), providing more financial flexibility.
Bottom Line
NVS scores higher overall (51/100 vs 43/100), backed by strong 22.5% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
High Tide Inc
HEALTHCARE · PHARMACEUTICAL RETAILERS · USA
High Tide Inc. is a vertically integrated company in the cannabis market in Canada, the United States and internationally. The company is headquartered in Calgary, Canada.
Visit Website →Novartis AG ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Visit Website →Compare with Other PHARMACEUTICAL RETAILERS Stocks
Want to dig deeper into these stocks?